UNICHEMLABNSEUnichem Laboratories Limited· PharmaceuticalsLowNeutral
Announced Fri, 4 Jul · 10:24 IST

Unichem Laboratories Limited has informed the Exchange regarding 'Notice of 62nd Annual General Meeting.'

Board & Shareholder Meetings View source PDF

UNICHEMLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Unichem Laboratories has filed the notice for its 62nd Annual General Meeting to be held on Monday, 4th August 2025 at 3:00 PM via video conferencing, for the financial year 2024-25. Key agenda items include adoption of audited standalone and consolidated financial statements for FY25 and re-appointment of Dr. Prakash A. Mody, who retires by rotation. Three related party transactions are up for shareholder approval covering business with Ipca Laboratories (the holding company that owns 52.67% of Unichem) and Unichem USA (wholly owned subsidiary), with combined limits of up to ₹2,400 crores for FY2026. Shareholders will also approve the appointment of M/s Alwyn Jay & Co. as Secretarial Auditors for five years (FY2025-30) and ratify ₹6 lakh remuneration to Kishore Bhatia & Associates as Cost Auditors for FY26.

Likely market impact

This is a routine AGM notice with no major surprises, so immediate stock impact is likely muted. However, the large ₹2,400 crore combined RPT ceiling with the parent Ipca group is worth tracking, as it reflects deep operational integration between the companies and warrants shareholder attention to ensure arm's-length pricing.